ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2766

Seasonal Variation in Incidence of Giant Cell Arteritis: A Population-Based Cohort Study

Shafay Raheel1, Cynthia S. Crowson2 and Eric L. Matteson3, 1St. Joseph's Hospital, Chicago, IL, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, giant cell arteritis and population studies

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To determine whether there is a seasonal peak onset of giant cell arteritis (GCA). We examined the seasonal variability of GCA in a geographically-defined population.

Methods: In a geographically defined population, we retrospectively identified all incident cases of GCA between January 1, 1950, and December 31, 2009. Detailed review of all individual medical records was performed. All included patients met the 1990 ACR criteria for classification of GCA. Seasonal variation was compared using quasi-Poisson regression models to account for overdispersion.

Results:   The cohort included 248 cases of incident GCA (79% female; mean age 75.6 years). Overall, patients in this cohort were more likely to have incident GCA in the summer season with age- and sex-adjusted incidence rates (per 100,000 population) of 5.5 for summer compared with 4.7 for winter, 3.9 for spring and 4.3 for autumn, but this difference did not reach statistical significance (p=0.19). However, subgroup analysis by decade revealed that incidence of GCA was significantly highest (p=0.018) in the summer season and lowest in the spring during 1995-2009 with an age-adjusted and sex-adjusted incidence rate per year 100,000 of 6.8 compared with winter (4.9), spring (2.7) and autumn (5.0) [Figure].

 Figure. GCA incidence rates by season and decade (1950-79 open circles, 1980-94 squares, 1995-09 filled circles) among Olmsted County, Minnesota residents in 1950-2009

 

 

Conclusion: Incident GCA is more common in the summer season and least common in the spring. This pattern is more pronounced in recent years. Further research needs to be done in order to understand whether these findings provide insights regarding the etiology of GCA.


Disclosure: S. Raheel, None; C. S. Crowson, None; E. L. Matteson, None.

To cite this abstract in AMA style:

Raheel S, Crowson CS, Matteson EL. Seasonal Variation in Incidence of Giant Cell Arteritis: A Population-Based Cohort Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/seasonal-variation-in-incidence-of-giant-cell-arteritis-a-population-based-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-variation-in-incidence-of-giant-cell-arteritis-a-population-based-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology